Yang and colleagues confirmed that overexpression of miRNA-182 enhanced the proliferative and metastatic capabilities of CRC cells by targeting the 3′-UTR of special AT-rich sequence binding protein 2 (SATB2) and caused tumor cells to undergo epithelial-mesenchymal transition (EMT) [42]. The gene discussed is SATB2; the disease is neoplasm.